Now I have enough information to write the final review. Let me synthesize everything.

---

## Summary

ProteinVista introduces a compute-efficient 3D convolutional neural network that encodes full-atom protein structures as voxelized 3D grids. Pre-trained on over 500,000 AlphaFold-2 structures using a contrastive objective aligned to ESM-2 embeddings, the model (123M parameters) outperforms the much larger ESM-2 650M on three structure-dependent binding prediction tasks: enzyme-substrate classification, transporter-substrate classification, and IC₅₀ regression, while requiring ~1% of the GPU-hours for pre-training. An ensemble of ProteinVista and ESM-2 further improves performance, demonstrating complementary sequence and structure signals.

## Strengths

- **Decisive performance on structure-dependent tasks with far fewer resources**: ProteinVista achieves R² = 0.69 on IC₅₀ regression vs 0.61 for ESM-2 650M (p < 10⁻³⁰⁴ by one-sided Wilcoxon), and MCC = 0.77 on transporter-substrate classification vs 0.74 for ESM-2 650M (Table 1). These gains come with 123M parameters, ~1% of ESM-2's pre-training GPU-hours, and pre-training on ~0.5M structures vs ~250M sequences (Section 4.3, Figure 3).

- **Well-demonstrated complementarity between structure and sequence**: Averaging ProteinVista and ESM-2 predictions improves over either model alone on all binary benchmarks, with transporter-substrate accuracy rising to 91.5% (McNemar's p < 10⁻¹³; Section 3.2). Stratification by sequence identity, TM-score, and pLDDT (Figure 2a–c) consistently shows the ensemble outperforming individual models across all similarity regimes.

- **Thorough analysis and honest negative control**: The paper stratifies results by sequence identity, structural similarity, and AlphaFold-2 confidence (Figure 2a–d), revealing *when* structural information matters. On GO term prediction — a homology-driven task — ProteinVista underperforms ESM-2 (Fmax 0.57 vs 0.62; Section 3.4), appropriately delineating the method's regime of value rather than claiming universal superiority.

- **Rigorous ablation study**: Single-variable perturbations (Figure 2e) quantify contributions: removing multi-view averaging drops R² by 6.4%, switching contrastive for Rosetta regression pre-training drops R² by 1.0%, and reducing resolution to 1.5Å drops R² by 1.1%. The Rosetta-only ablation is particularly important — it shows that a pre-training objective *not using ESM-2* yields almost identical performance (R² ≈ 0.683, still well above ESM-2's 0.61).

- **Practical engineering choices**: Adaptive cubic box sizing (64³–160³) minimizes empty voxels; continuous Gaussian atomic densities (σ = 1Å) reduce discretization artifacts (Section 2.1); open-source Python implementation provided.

## Weaknesses

### Fatal

None.

### Major

- **Ablation limited to IC₅₀ regression only**: The Rosetta-only pre-training ablation — which is critical for establishing that ProteinVista's gains are not merely distilled from ESM-2 — is reported only for the IC₅₀ task (Figure 2e). While the 1% drop on IC₅₀ is reassuring, we do not know whether Rosetta-pre-trained ProteinVista would still outperform ESM-2 on the transporter-substrate and enzyme-substrate binary classification tasks. Since these benchmarks are central to the paper's claims, the absence of this control across all tasks is a genuine evidential gap. The contrastive objective uses ESM-2 as a teacher signal, so comparing the student against the teacher requires showing that an independently pre-trained variant (Rosetta-only) also succeeds across all benchmarks, not just one.

- **Pre-training/downstream data split not discussed**: The paper pre-trains on >500,000 Swiss-Prot AlphaFold-2 structures but does not state whether proteins appearing in the downstream test sets (TSP, ESP, BindingDB, GO) were excluded from pre-training. While pre-training is unsupervised (no task labels are used), the model may have seen 3D coordinates of test proteins during pre-training, which could inflate the quality of learned representations relative to ESM-2 (which was pre-trained on sequences, not structures). The paper should address this.

### Minor

- **Cropping of large proteins not quantified**: The paper states that structures exceeding the 160³-voxel grid are cropped (Section 2.1) but does not report how many proteins this affects, whether cropping biases evaluation toward smaller proteins, or how performance on cropped vs uncropped proteins compares. For a model marketed as encoding full-atom detail, this is a gap in the analysis.

- **Discrete rotation augmentations only**: Augmentations are limited to 90° rotations and mirror reflections (Section 2.4). While multi-view averaging at inference partially addresses this, the paper does not verify robustness to arbitrary continuous SO(3) rotations, which would strengthen the claim of rotation-robust representations.

### Trivial

- The ablation disabling augmentations during fine-tuning shows virtually no impact (-0.1%), yet the paper could clarify whether this implies the pre-training augmentations are sufficient to learn rotation-robust features, or whether the task itself has limited rotational sensitivity.

## Nice-to-Haves

- Extending the Rosetta-only pre-training variant to TSP and ESP benchmarks would fully resolve the teacher-student circularity concern.
- A 3D Grad-CAM-style visualization (mentioned in the Discussion as future work) would strengthen the paper's interpretability claims.
- Reporting how performance varies between cropped and uncropped proteins.
- Exploring whether continuous rotation augmentations or an equivariant architecture would further improve results.

## Removed Points

These points are flagged to be removed; treat them with caution:

1. **"The contrastive pre-training objective makes the comparison circular and uninterpretable" (from Harsh Critic, labeled structural/fatal)**: REMOVED as a fatal claim. The paper *does* report a Rosetta-only pre-training variant. On IC₅₀, it shows only a 1.0% relative R² drop (from 0.69 to ~0.683), still far above ESM-2's 0.61. This directly refutes the claim that the gains are purely from distilling ESM-2. The concern about circularity is demoted to Major only because the Rosetta ablation is missing for TSP/ESP — but the evidence that exists contradicts the fatal framing.

2. **"Likely pre-training / downstream task overlap (evidential)" labeled as a serious gap**: RETAINED but demoted to Major. The concern is legitimate but applies symmetrically to ESM-2 (pre-trained on sequences that may include downstream proteins). Since pre-training is unsupervised (no task labels), this is a representation-quality concern rather than label leakage. Should be discussed but is not a fatal flaw.

3. **"No evidence of robustness to arbitrary continuous SO(3) rotations"**: DEMOTED to Minor. The multi-view averaging partially addresses this, and the ablation showing no fine-tuning augmentation impact (-0.1%) is consistent with a model that has learned stable representations. This is a nice-to-have, not a core flaw.

4. **Strength Finder claim about "SOTA" on TSP/ESP via ESM-ProteinVista_OP**: PARTIALLY RETAINED. The optimized pipeline comparison (Table 1) uses a different training protocol than the main comparison (fine-tuned MolFormer, contrastive network, averaging), so it's not a pure structure-only result. However, the paper is transparent about this and the main claim rests on the head-to-head comparison under identical conditions. The optimized-pipeline result is presented as a demonstration of what's possible, not as the core contribution.

5. **Generic strengths removed**: "The problem is important" and "The writing is clear" are generic observations with no specific evidence, dropped from Strengths.

## Novel Insights

The most interesting finding is the task-dependent value of structure: ProteinVista's advantage is large on IC₅₀ regression (where fine-grained binding-pocket geometry dominates), moderate on transporter/enzyme substrate classification, and negative on GO term prediction (where sequence homology suffices). This gradient, combined with the stratification analyses by sequence identity and structural similarity, provides a nuanced picture of when and why explicit 3D structural encoding matters — something that sequence-vs-structure comparisons in the literature rarely characterize with this level of granularity.

## Suggestions

- Run the Rosetta-only pre-trained ProteinVista on TSP and ESP to close the evidential gap on whether structural information alone (without ESM-2 distillation) drives the gains across all benchmarks.
- Add a brief statement clarifying whether downstream test proteins were excluded from the pre-training set, and if not, discuss the implications.
- Report the frequency and impact of cropping for proteins exceeding the 160³ grid.

---

## Score and Decision

### Calibration anchor summary

| Anchor | Path | Avg Score | Round | Comparison |
|--------|------|-----------|-------|------------|
| rEQ8OiBxbZ | LEGO molecular pretraining | 3.00 | R1 (weak) | Weaker — narrow geometric pretraining task, less comprehensive evaluation |
| m9zWBn1Y2j | PsiDiff ligand conformation | 3.00 | R1 (weak) | Weaker — single-task, less thorough |
| nWO75tVjfp | CompassDock | 3.00 | R1 (weak) | Weaker — analysis tool, not a model contribution |
| jqx5XI4Yr3 | ProteinAdapter | 3.40 | R1 (weak) | Weaker — adapter method with limited novelty |
| xNDydjYBmC | PPBind affinity prediction | 4.60 | R1 (mid) | Weaker — narrower scope, less thorough evaluation |
| umUIYdLtvh | EquiPocket (3D CNN for binding sites) | 5.50 | R1 (mid) | Our paper is stronger — more tasks, better ablation, ensemble analysis |
| AXbN2qMNiW | BindNet binding representation | 5.67 | R1/R2 (mid) | Our paper is stronger — BindNet had data leakage concerns and missing ESM-2 baselines |
| BEH4mGo7zP | ProteinINR (sequence+structure+surface) | 5.75 | R2 (narrow) | Our paper is stronger — ProteinINR showed marginal gains, our paper shows clearer improvements |
| xcMmebCT7s | PPIformer (PPI design) | 5.80 | R2 (narrow) | Different task but comparable quality; our paper has more thorough analysis |
| A1HhtITVEi | CheapNet binding affinity | 6.00 | R1 (mid) | Comparable — CheapNet has methodological novelty but less thorough evaluation and weaker writing |
| sTYuRVrdK3 | ProteinWorkshop benchmark | 6.25 | R2 (narrow) | Comparable — benchmark paper vs model paper, different contributions; our paper has stronger empirical results |
| 5z9GjHgerY | DPLM-2 multimodal diffusion PLM | 6.33 | R2 (narrow) | Slightly stronger — DPLM-2 has more methodological novelty (multimodal diffusion) |
| 4S2L519nIX | All-atom geometric GNN pretraining | 6.50 | R2 (narrow) | Slightly stronger — broader scope with zero-shot transfer, more extensive GNN exploration |
| owEQ0FTfVj | GlycanML benchmark | 6.67 | R2 (narrow) | Different domain (glycans), not directly comparable |
| 6MRm3G4NiU | SaProt structure-aware PLM | 7.33 | R2 (narrow) | Stronger — SaProt is a genuinely novel foundation model with broader impact |

**Round-1 bracket**: 5.0–6.5. The paper is clearly above the weak band (3.0–3.4, all rejected), clearly below the strong band (7.5+, all top-tier generative protein models), and sits in the middle. The most comparable anchors (EquiPocket 5.5, BindNet 5.67, CheapNet 6.0, ProteinWorkshop 6.25) bracket our paper.

**Round-2 narrowing**: The ProteinINR paper (5.75) had marginal performance gains and limited novelty — our paper is stronger. CheapNet (6.0) had unclear writing and limited novelty — our paper is comparable or slightly better in empirical evaluation but has its own teacher-signal concern. The all-atom geometric GNN paper (6.50) and SaProt (7.33) are clearly stronger in terms of novelty and impact.

The paper lands at **6.0**: stronger than the 5.5–5.75 papers that were accepted or borderline, comparable to CheapNet (6.0, accepted), and weaker than the 6.25+ papers. The ESM-2 teacher concern (mitigated but not fully resolved across all benchmarks) and the missing data-split discussion prevent a higher score, but the thorough empirical work, honest negative control, and demonstrated complementarity with sequence models make this a solid contribution.

MY FINAL SCORE: <score>6.0</score>
MY FINAL DECISION: <decision>Accept</decision>